Beth Israel Deaconess Medical Center Selects M*Modal to Provide Speech Understanding™ Platform

M*Modal to Integrate its Technology with Leading Medical Center’s Own Radiology Information System

PITTSBURGH--(BUSINESS WIRE)-- M*Modal announced today that it has been selected as a strategic partner by Beth Israel Deaconess Medical Center (BIDMC) of Boston, MA, one of the nation’s premier healthcare organizations. M*Modal will integrate its Speech Understanding™ technology with BIDMC’s proprietary Radiology Information System (RIS) in order to provide voice-driven radiology reporting capabilities. The integrated system will support a department with over 600 full time employees (FTEs) that completes more than 300,000 exams annually across all modalities and generates approximately 800,000 minutes of dictation.

BIDMC selected M*Modal as part of a strategic initiative in which the medical center sought to provide a complete solution that would launch directly from BIDMC’s RIS and offer flexible workflow options for the radiologists. A major emphasis is on promoting self-completion of reports for optimal efficiency.

“M*Modal is best able to meet our requirements for a solution that tightly integrates with our RIS and that will produce higher quality and far more efficient reporting as a result,” said Allen Reedy, Radiology Business Director at Beth Israel Deaconess. “In addition, M*Modal’s ability to generate structured documentation automatically from narrative is a major plus and is consistent with BIDMC’s objectives.”

Unlike commonly used speech recognition technologies, M*Modal’s Speech Understanding technology combines advanced speech and natural language processing (NLP) technologies in one unified platform. The results of this approach are superior speech recognition and automatic output not simply of tagged data elements but also of highly meaningful information that drives medical action. The M*Modal platform is deployed as a Software-as-a-Service (SaaS) model.

“BIDMC conducted a rigorous investigation of the technological options, and we are pleased that our platform has met their high standards,” said Michael Finke, M*Modal CEO. “Our strategy of delivering meaningful clinical content from narrative is a driving factor in M*Modal’s growing adoption by leaders such as BIDMC.”

M*Modal works with a wide variety of clinical documentation, RIS/PACS, EHR, and other solutions partners who leverage the unique Speech Understanding platform.

About M*Modal:

M*Modal, the market leader in advanced Speech Understanding technology, combines industry leading technology and clinical documentation services to produce highly accurate, structured, encoded and shareable medical documents to facilitate the use and adoptability of electronic health records. More than 800 healthcare organizations nationwide utilize M*Modal’s solutions to increase patient safety and promote continuity of patient care. For more information, please visit www.mmodal.com.

About Beth Israel Deaconess Medical Center:

Beth Israel Deaconess Medical Center is a patient care, teaching and research affiliate of Harvard Medical School, and consistently ranks among the top four in National Institutes of Health funding among independent hospitals nationwide. BIDMC is clinically affiliated with the Joslin Diabetes Center and is a research partner of Dana-Farber/Harvard Cancer Center. BIDMC is the official hospital of the Boston Red Sox. For more information, visit www.bidmc.org.



CONTACT:

Aria Marketing
Jessica Cohen, 617-332-9999 ext. 203
[email protected]

KEYWORDS:   United States  North America  Massachusetts  Pennsylvania

INDUSTRY KEYWORDS:   Technology  Data Management  Networks  Software  Practice Management  Health  Hospitals  Other Health

MEDIA:

Logo
 Logo

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.